A previous study showed that copper regulates key signaling pathways that underlie PD-L1-mediated immune evasion in cancer; reducing copper levels in tumor cells with copper chelators increases CD8+ T cells and inhibits cancer progression (Voli et al., 2020). This evidence concerns the gene CD8A and neoplasm.